By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Celera reported after the close of the market Wednesday that its fourth-quarter revenues declined 15 percent due to a drop in its lab services receipts.

The Alameda, Calif.-based molecular diagnostics firm brought in total revenues of $40 million for the three-month period ended Dec. 26, 2009, down from revenues of $47.3 million for the fourth quarter of 2008. The results edged analysts' consensus estimate of $39.6 million for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.

Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.

Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.

Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.